Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing

Dec 8, 2024European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Genome editing using CRISPR/Cas9 complexes that respond to two different acidity levels

AI simplified

Abstract

The most potent LAF-dGtp analogues achieved an EC50 of 0.51 nM in a Duchenne muscular dystrophy reporter cell line.

  • Dual pH-responsive amphiphilic xenopeptides were evaluated for delivering CRISPR/Cas9 RNP.
  • Enhanced cellular uptake and effective endosomal disruption were observed in HeLa cells.
  • Cas9/sgRNA RNP complexes demonstrated potent genome editing capabilities across four different cell lines.
  • Comparative analysis showed similar splice site editing and exon skipping between Cas9/sgRNA RNP complexes and Cas9 mRNA/sgRNA polyplexes.
  • A carrier complexing Cas9/sgRNA RNP and donor DNA facilitated up to 43% homology-directed repair in HeLa cells.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free